Search Results 231-240 of 1089 for 外贸网站建设 推广,雅虎seo,宁波seo搜索引擎优化,海外应用推广,找关键词优化公司等欢迎访问六五Ai站群搜尋引擎系統V.25.05.20官方网站:www.65.hk

1. Validation of a Blood Assay for the Detection of BRAF Mutation Status in Patients with Metastatic Melanoma - Mayo Clinic

   The purpose of this study is to validate an internally developed assay for the detection of BRAF V600E mutations in cfDNA from the peripheral blood of patients ...

2. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

   Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether temozolomide is more ...

3. Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma - Mayo Clinic

   The purpose of this study is to determine the safety and effectiveness of bb2121 (Ide-Cel) combinations in subjects with relapsed/refractory multiple myeloma.

4. Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients with Refractory Advanced Solid Tumors - Mayo Clinic

   The purpose of this study is to evaluate the safety and tolerability of the investigational drug VLX600 in patients with refractory advanced solid tumors.

5. A Study to Evaluate Ultrasound Imaging in Renal Transplant Recipients - Mayo Clinic

   The purpose of this study is to determine the effectiveness of ultrasound elastography in prediction of renal allograft fibrosis. Participation eligibility.

6. A Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS) - Mayo Clinic

   The primary purpose of this study is to assess progression-free survival of men who have oligometastatic prostate cancer after randomization to stereotactic ...

7. A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread - Mayo Clinic

   Many hormone receptor positive breast cancers demonstrate overexpression of cyclin D. Cyclin D interacts directly with cyclin-dependent kinases 4 and 6 (CDK4/6) ...

8. Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis - Mayo Clinic

   ... 6 months for up to 5 years from the date of enrollment. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease ...

9. Funding - Neuromotor Behavior and Locomotion: Farwa Ali - Mayo Clinic Research

   INVESTIGATOR & ROLE. GRANT TITLE. FUNDING SOURCE. DURATION. Farwa Ali, M.B.B.S. Principal Investigator, Mechanisms of Gait and Balance Impairment in ...

10. Esophageal cancer - Doctors and departments - Mayo Clinic

    Esophageal cancer — Comprehensive overview covers symptoms, causes, types, risks, treatment of cancer of the esophagus.